Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Parexel sees signs of recovery in Q2 figures

February 2, 2010 Research and Development CRO, Parexel

Contract research organisation Parexel International’s second-quarter net profit fell 34% to $3.5 million on restructuring and investment-impairment charges, but still …
News

Job cuts at GlaxoSmithKline and AstraZeneca

February 2, 2010 Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline

Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …
News
Lilly laboratory

Lilly signs diabetes deal with Alizé Pharma

February 2, 2010 Research and Development Alize, diabetes, lilly, type II

Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …
News

Contract research news in brief

February 2, 2010 Research and Development CRO, PRA, Quintiles

Our round-up of contract research news includes alliances for Quintiles and PRA International, a new CRO serving the Eastern European …
News

Gates’ $10 billion vaccines pledge to cut child mortality

February 1, 2010 Research and Development, Sales and Marketing Gates Foundation, developing world, vaccines

Bill and Melinda Gates are to spend $10 billion over the next 10 years to help research, develop and deliver …
News

Pfizer abandons 100 projects in R&D streamlining

January 28, 2010 Research and Development Pfizer

Pfizer has released details of its new consolidated pipeline following its merger with Wyeth, announcing new priority research areas, and …
News

Cell Medica bolsters senior management

January 28, 2010 Research and Development Cell Medica, appointment, research and development

London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …
Appointment

UK’s research ‘Super Cluster’ unveiled

January 27, 2010 Research and Development, Sales and Marketing ABPI, clinical research, innovation, patent box

GlaxoSmithKline chief executive Andrew Witty has hailed a new UK government ‘blueprint’ to help improve the country’s competitiveness in the …
News

Romaco and Ankur target oral film strip market

January 27, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Ankur, Romaco, drug delivery, film strips

Packaging and processing technology specialist Romaco has kitted out Indian drugmaker Ankur Drugs and Pharma with a production line for …
News

BioCeramic Therapeutics appoints Ian Brown

January 27, 2010 Research and Development BioCeramic Therapeutics, appointment, research and development

BioCeramic Therapeutics has appointed Ian Brown chief executive, taking over from Daniel Green who will remain on the board as …
Appointment

In brief: European Medicines Agency news

January 26, 2010 Research and Development, Sales and Marketing Arepanrix, Arzerra, EMEA, GSK, Tysabri

GlaxoSmithKline’s influenza vaccine Arepanrix has been granted conditional marketing authorisation in Europe under an emergency fast-track procedure.It is the fourth …
News

Quintiles re-positions itself for changing biopharma industry

January 26, 2010 Research and Development, Sales and Marketing CRO, Quintiles

Leading services company Quintiles has unveiled a new corporate identity to help showcase the diversity of its business.The company, best …
News
Blog footer

Digital Pharma – Online patient recruitment drive for GSK’s anxiety drug

January 26, 2010 Research and Development GlaxoSmithKline, PTSD, digital research, orvepitant, patient recruitment

GlaxoSmithKline is readying to move its post-traumatics stress disorder candidate orvepitant into phase II trials, a move being supported by …
Feature

Huge drug discovery database launched

January 26, 2010 Research and Development ChEMBLdb, Wellcome, genome, genomics

A huge online database of information on the properties and activities of drugs and drug-like small molecules and their targets …
News

Roche invests in production of new Herceptin formulation

January 25, 2010 Manufacturing and Production, Research and Development Herceptin, Roche

Roche will spend 190 million Swiss francs ($183m) to put production capacity in place for a new self-administered formulation of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025